CBRAIN (C6F) fair value: what the stock is really worth
As of Jul 17, 2026: fair value of CBRAIN €2.14, price €6.85, upside -68.8%, quality 65 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch CBRAIN for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range €6.49 – €63.39 · fair‑value band €1.50 – €2.78 · the €6.85 price screens above the €2.14 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow CBRAIN in your weekly email
Every Wednesday you see whether CBRAIN is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
CBRAIN (C6F) currently trades at €6.85, while our model-based Fair Value estimate is €2.14, 68.8% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of €1.31 per share, and 0 of the 24 models we run sit above the €6.85 price.
Bear case: the Asset-Based group reads lowest at €0.2800, and 24 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: €1.50 (bear) to €2.78 (bull), the price of €6.85 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 65/100 (solid quality), in the Other sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
CBRAIN reported revenue of 251M DKK in FY2025 versus 155M DKK in FY2021, a compound +12.9%/yr. Reported net income was 43.1M DKK in FY2025, compounding +8.6%/yr from FY2021.
Key figures
Market cap €701M · Dividend yield 0.3% · Net margin 17.2% · Return on assets (EBIT) 19.2% · Free cash flow 56.6M DKK · Net debt 26.6M DKK.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 73% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Other peers we cover trades at −10% fair-value upside, at −69%, C6F screens richer than that median.
Fair Value models
Bear €1.50Fair Value €2.14Bull €2.78
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.84/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−6.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.9%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.9%
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+23.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+22.7%
Dividend (yield on the price)0.3%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.17% → 23%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+10.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in DKK, Denmark: IMF forecast 2.1% a year to 2030, 2.0% from 2016 to 2025) that is about +7.9% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Other · 114 stocks
Beats the industry median on 5/8 measures
Overall it ranks above its industry peers.
Valuation
Quality Score65 · Top 25%
Fair Value upside−68.8% · Bottom 25%
Profitability
Return on assets0.0% · Above median
Net margin (TTM)17.2% · Top 25%
Operating margin (TTM)0.0% · Above median
Growth and dividend
Revenue growth0.0% · Top 25%
Dividend yield (TTM)0.3% · Below median
Balance sheet
Debt / equity0.08× · Above median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 23
FUTURE (revenue growth)0· sector 0
PAST (return on equity)0· sector 0
HEALTH (low debt)96· sector 98
DIVIDEND (yield)7· sector 24
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "CBRAIN Fair Value". https://www.fairvalue-calculator.com/stock/C6F
Frequently asked questions
Is CBRAIN (C6F) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of €2.14 versus the last price from Jul 17, 2026 of €6.85, about −69% upside (overvalued).
What is the fair value of C6F?
Our model-based fair value for CBRAIN is €2.14 (as of Sep 24, 2026), built from audited fundamentals. Last price (from Jul 17, 2026): €6.85.
What is the quality score of C6F?
CBRAIN has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CBRAIN (C6F)?
Our model-based price target is the fair value of €2.14 (as of Sep 24, 2026) from 24 valuation models. Cautious scenario €1.50, optimistic scenario €2.78. It is a calculation from audited fundamentals, not an analyst target.
What is the CBRAIN stock forecast for 2026?
Our models put fair value at €2.14, about −69% upside versus the last price from Jul 17, 2026 of €6.85 (overvalued). Cautious scenario €1.50, optimistic scenario €2.78. The calculation is refreshed regularly with new filings.
Does CBRAIN pay a dividend?
CBRAIN currently shows a dividend yield of about 0.33% relative to its recent price (as of Sep 24, 2026).
What growth is priced into CBRAIN (C6F)?
For today's price to be fair in a discounted-cash-flow model, CBRAIN would have to grow free cash flow by +10.1 % per year for five years (discount rate 11.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +15.9 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of C6F use?
Our models discount CBRAIN at 11.0 %: a base by market capitalisation (small), country premium for Germany. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For CBRAIN that is +10.1 % per year a year over ten years, using the same discount rate (11.0 %) and the same formula as our fair value.
How much growth has CBRAIN (C6F) delivered so far?
Over the past 5 years revenue at CBRAIN grew +15.9 % a year. The price currently implies +10.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of CBRAIN (C6F) growing?
The median revenue growth in the sector is +8.1 % a year. That is the yardstick for the growth priced into CBRAIN (+10.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of CBRAIN (C6F)?
The free-cash-flow yield on the price is 5.65 %: that much free cash flow CBRAIN produces per unit of market value. When it exceeds the discount rate of our models (11.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of CBRAIN (C6F)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CBRAIN it is €2.14 per share (as of Sep 24, 2026), against a price of €6.85. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is CBRAIN stock overvalued or undervalued in 2026?
As of Sep 24, 2026, C6F trades above its calculated fair value: price €6.85, fair value €2.14, a gap of about −69% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of C6F?
No. The price is what the market pays today (€6.85); the fair value is what the company's own numbers justify (€2.14). For CBRAIN the two are €4.71 per share apart. That gap is exactly why we show both numbers side by side.
How much is CBRAIN worth?
The market values CBRAIN at about €701M (market capitalisation, as of Sep 24, 2026). Per share that is €6.85; our models calculate a fair value of €2.14 per share.
What do the bullish and bearish scenarios say about C6F?
Our models span a range for CBRAIN: cautious scenario €1.50, base €2.14, optimistic €2.78 per share (as of Sep 24, 2026, price €6.85). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of CBRAIN (C6F)?
Balance-sheet figures for CBRAIN (as of Sep 24, 2026): debt of 0.08 per unit of equity. They feed the Quality Score of 65/100, which measures business quality independently of the share price.
How far is C6F from its 52-week high?
CBRAIN trades at €6.85, about 73% below its 52-week high of €25.25 and 6% above the low of €6.49 (as of Jul 17, 2026). Distance from the high says nothing about value: that is what the fair value of €2.14 is for.
Which stocks are comparable to CBRAIN?
From the same area (Other) we also value 542772, 590024, Indiabulls Real Estate Limited, 542851, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CBRAIN stock attractive at the current price?
The data as of Sep 24, 2026: price €6.85, calculated fair value €2.14 (−69%), Quality Score 65/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of C6F calculated?
We run CBRAIN through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €2.14, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. CBRAIN itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CBRAIN (C6F)?
The latest price we hold is from Jul 17, 2026 and stands at €6.85. Our model-based fair value is €2.14, about −69% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CBRAIN right now?
The price sits above even our optimistic bull case (€2.78). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (€1.50 to €2.78) leaves room in how you read the outcome.
Key figures of CBRAIN
How large is the market capitalisation of CBRAIN (C6F)?
The market capitalisation of CBRAIN is €701M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the dividend yield of CBRAIN (C6F)?
The dividend yield of CBRAIN is 0.3%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of CBRAIN (C6F)?
The net margin of CBRAIN is 17.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of CBRAIN (C6F)?
On an EBIT basis the return on assets of CBRAIN is 19.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much net debt does CBRAIN (C6F) carry?
The net debt of CBRAIN is 26.6M DKK (fiscal year 2024, ≈ 0.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch CBRAIN in the live analysis
One click puts CBRAIN on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
